Matsunaga J, Dakeishi M, Shimizu H, Tomita Y
Department of Dermatology, Akita University School of Medicine, Japan.
J Dermatol Sci. 1996 Nov;13(2):134-9. doi: 10.1016/s0923-1811(96)00519-1.
We examined the tyrosinase gene of two Japanese patients with tyrosinase-negative oculocutaneous albinism by allele-specific amplification analysis on two known point mutations in Japanese, and the results indicated that they were compound heterozygouts, namely, one allele of the tyrosinase gene harbored one of two known mutations and another allele probably had a mutation unknown in Japanese patients. Therefore, we have cloned and sequenced the tyrosinase gene of the two patients and identified two different point mutations. One is a nonsense mutation, codon 278CGA (Arg) to TGA (TER), and the other is a substitution mutation, codon 431CCA (Pro) to CTA (Leu). However, these same mutations have already been observed in a Guyanan and a Moroccan Jewish patient, and in an Indo-Pakistani patient, respectively.
我们通过对两个已知的日本酪氨酸酶基因点突变进行等位基因特异性扩增分析,检测了两名日本酪氨酸酶阴性眼皮肤白化病患者的酪氨酸酶基因,结果表明他们是复合杂合子,即酪氨酸酶基因的一个等位基因携带两个已知突变之一,另一个等位基因可能有日本患者中未知的突变。因此,我们克隆并测序了这两名患者的酪氨酸酶基因,鉴定出两个不同的点突变。一个是无义突变,密码子278CGA(精氨酸)突变为TGA(终止密码子),另一个是替换突变,密码子431CCA(脯氨酸)突变为CTA(亮氨酸)。然而,这些相同的突变分别已在一名圭亚那患者和一名摩洛哥犹太患者以及一名印度 - 巴基斯坦患者中观察到。